Taken together, through single-cell assessment, our data enabled us to identify analogous Spp1hi-TAMs with elevated immunosuppressive gene signatures across multiple mouse models of prostate cancer, and we subsequently demonstrated their resistance to CSF1R inhibition. This evidence concerns the gene CSF1R and prostate carcinoma.